anesthesia and glp-1 glp 1 gastric emptying GIP in Type 1 Diabetes Therapy: A Time for Reappraisal? Glucagon-Like Peptide-1 Receptor Agonists in

How is the 2.5 mg starting dose drawn on a U-100 syringe

Its metabolism-boosting and appetite-suppressing properties can help individuals achieve their weight loss goals more effectively

This study highlights that: Delayed gastric emptying is clinically significant Standard fasting guidelines may be insufficient Gastric ultrasound is a valuable tool for risk stratification As GLP-1 use continues to expand, anesthesiologists must adapt their practices to ensure patient safety

Drawing too many or too few units means you will receive the wrong dose of medication

That is why I tend to frame GLP-1 therapy as one tool within a broader system of care: medical evaluation, nutrition guidance, progressive exercise, load management, and when appropriate, a transition into structured strength training